ReWalk Robotics (NASDAQ:LFWD – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.50) EPS for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03, Zacks reports. The company had revenue of $6.71 million during the quarter, compared to analysts’ expectations of $6.71 million. ReWalk Robotics had a negative return on equity of 39.72% and a negative net margin of 102.03%. During the same quarter in the previous year, the firm posted ($0.35) EPS. ReWalk Robotics updated its FY 2024 guidance to EPS.
ReWalk Robotics Stock Down 8.6 %
Shares of LFWD traded down $0.35 during mid-day trading on Friday, reaching $3.72. The company had a trading volume of 73,515 shares, compared to its average volume of 44,008. The stock has a 50 day moving average of $3.97 and a two-hundred day moving average of $4.84. The stock has a market capitalization of $32.44 million, a P/E ratio of -1.20 and a beta of 2.06. ReWalk Robotics has a 52-week low of $3.00 and a 52-week high of $9.10.
Analyst Ratings Changes
A number of equities research analysts recently commented on LFWD shares. HC Wainwright lifted their target price on ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a report on Friday. Lake Street Capital raised shares of ReWalk Robotics to a “strong-buy” rating in a report on Monday, June 24th.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Recommended Stories
- Five stocks we like better than ReWalk Robotics
- Earnings Per Share Calculator: How to Calculate EPS
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What is the Euro STOXX 50 Index?
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.
